Insider track record
OtherAcross 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by Blume-Jensen Peter. Director active across 1 company, notably Acrivon Therapeutics, Inc.. Aggregated, 19 filings have been published. Activity tracked since 14 November 2022. The latest transaction was disclosed on 21 May 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations19 total
13,729 shares@ US$1.790.5% of flowCommon StockSEC:0000905148-26-002652:0
14,265 shares@ US$1.530.5% of flowCommon StockSEC:0000905148-26-001010:0
19,904 shares@ US$2.301.0% of flowCommon StockSEC:0000905148-25-004179:0
59,765 shares@ US$2.242.9% of flowCommon StockSEC:0000905148-25-004127:0
490 shares@ US$2.240.0% of flowCommon StockSEC:0000905148-25-004127:1
19,904 shares@ US$1.150.5% of flowCommon StockSEC:0000905148-25-001900:0
59,766 shares@ US$1.141.5% of flowCommon StockSEC:0000905148-25-001820:0
19,904 shares@ US$5.542.6% of flowCommon StockSEC:0000905148-25-000764:0
37,152 shares@ US$5.424.8% of flowCommon StockSEC:0000905148-25-000725:0
19,910 shares@ US$6.443.0% of flowCommon StockSEC:0000905148-24-003270:0
59,766 shares@ US$7.9211.2% of flowCommon StockSEC:0000905148-24-003223:0
79,616 shares@ US$9.1916.4% of flowCommon StockSEC:0000905148-24-002335:0
59,765 shares@ US$7.029.5% of flowCommon StockSEC:0000905148-24-002277:0
54,918 shares@ US$8.3610.6% of flowCommon StockSEC:0000905148-24-001483:0
41,861 shares@ US$3.403.3% of flowCommon StockSEC:0000905148-24-000760:0
239,023 shares@ US$5.0828.4% of flowCommon StockSEC:0000905148-23-001472:0
493,994 shares0Common StockSEC:0000905148-23-000783:0
33,605 shares@ US$3.883.1% of flowCommon StockSEC:0001140361-23-027860:0
934,731 shares0Common StockSEC:0001209191-22-057395:0